Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma

NCT00598507 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
35
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators